Shows
Schauer ThoughtsRest AND Digest? In This Economy?Welcome to the first Schauer of 2026, this week we’re discussing “brain washing” (a function of cerebrospinal fluid during sleep states) and integrating some g-dang information on the rest and digest system! Get ready for a gut-load of neuroscience and gastroenterology as well as a crude but functional amount of chemistry. Make sure to take your fiber after the communal STEAM session as sudden, public motility is frowned upon in most cultures.
I do apologize for mispronouncing molecules and neurological components, since I’m self-taught I don’t often get the experience to say these word...
2026-01-071h 23
KQED's ForumHow Artificial Intelligence is Used in HealthcareWhen you go to a medical appointment or get admitted into the hospital, your doctor may be using ChatGPT to save time. Artificial intelligence is already helping medical professionals organize treatment plans, diagnose diseases, and discover new drugs. In the future, it could do even more. We’ll talk to doctors and experts about how AI is being used and its potential and pitfalls in healthcare.Guests:Dr. Bryant Lin, physician and professor, Stanford School of Medicine - He is also a primary care doctor with Stanford Internal Medicine
2024-09-0557 min
Moral MattersSeason Finale | S8 : E11 | Bye - for now - and Hello to 43cc.Our season wraps up with Simon and Wendy discussing the whole experience of producing the 8 seasons of Moral Matters. We highlight excerpts from just a few of the amazing conversations we've had over the last four years: Jeremy Muller, Joe Crane, Blake Alkire, Rosemary Batt, Thom Mayer, Adam Beckman, Walter O'Donnell, L. Robert Burns, Ilana Yurkiewicz, and Luke Messac. We close with a teaser from 43cc, a new podcast co-hosted by Wendy Dean and Matt Ramsey that takes an irreverent look at healthcare, with a shot to dull the pain.
Link to 43cc podcast: https://podcasts.apple...
2024-08-2817 min
The Doctors On Social Media PodcastTraditional-Publishing A Book about Healthcare [Side Ventures]Ilana Yurkiewicz, MD joins our Side Ventures SERIES, to discuss the book writing process.We cover:the backstory of how to create a book through a traditional publishing outletthe steps of book publishinghow to get an agentwhat a book proposal is, what hers wasthe length of time from beginning to endDr. Yurkiewicz wrote the book Fragmented, which you can find more info about in our Books/Blogs section. Shoutouts & Links from this Episode:The Harvard Writing, Publishing and Social Media for Healthcare Professionals, which no longer t...
2024-06-0718 min
The Doctor's ArtNavigating the Gaps in Patient Stories | Ilana Yurkiewicz, MDIt's a cliche to say health care is broken. However, the extent to which it is unnecessarily convoluted, inefficient, and fragmented frustrates even the most experienced clinicians each time they are forced to deal with its consequences. Medical records disappear when a patient switches doctors. Critical details of life-saving treatment plans are buried deep within thousands of pages worth of electronic charts. In this episode, Stanford oncologist and journalist Ilana Yurkiewicz, MD explores all the ways that modern medicine is riddled with gaps and the incredible strain this puts on providers, patients, and caregivers alike. She is t...
2024-03-261h 02
Curiosity WeeklyChimp Menopause, Ancient Tsunami, Sexism in ScienceToday, you’ll learn about how a population of female chimps have surprisingly been found to go through menopause and live well beyond their reproductive years, an ancient tsunami and its devastating impact on stone age populations, and the dire effects of sexism in science. Chimp Menopause “Surprisingly long-lived wild female chimps go through menopause.” by Bruce Bower. 2023. “Wild Chimps Shown to Undergo Menopause for the First Time.” by Joanna Thompson. 2023. “Evolutionarily, grandmas are good for grandkids - up to a point.” by Sujata Gupta. 2019. “Why postmenopausal women are so crucial to our evolutionary success.” b...
2024-03-0812 min
The Doctors On Social Media PodcastOn Healthcare Fragmentation: A Conversation With Ilana Yurkiewicz [CONVERSATIONS]I sat across from Dr. Ilana Yurkiewicz recently, to discuss healthcare (this is Dr. Corriel writing)She’s not only a practicing internist at Stanford Medical Center, but also a graduate of Yale undergrad. To say she’s achieved success in life would be an understatement.But now, she’s doing more than practicing medicine. She’s advocating for change.Dr. Yurkiewicz recently published a book called Fragmented, through Norton Press, with years of award-winning medical journalism under belt.Listen to us converse about healthcare, check out her book, and stay...
2024-02-2923 min
Patient from HellEpisode 47: Why doesn’t my doctor know me? An examination of healthcare’s systemic failures featuring Dr. Ilana YurkiewiczEver experienced the frustration of feeling unheard, hastily ushered away, and checked off during your appointments? Or perhaps you've caught yourself making life-altering decisions hastily during your visits with your primary care provider? Join us in this episode as we unravel the systemic reasons behind these challenges and receive actionable tools to empower yourself, becoming an advocate for your health.
Key Highlights:
We get a peek into a typical clinician’s workday and the structural issues within it.
Three ways the healthcare system is fragmented: medical culture, loss to follow-up, and technology—and how...
2024-01-1048 min
The Short Coat: An Inside Look at Getting Into and Getting Through Medical SchoolWhat Medicine Really Needs From Artificial Intelligence, Ft. Ilana Yurkiewicz (Pt. 2)Bringing the healthcare pieces together
Dr. Ilana Yurkiewicz, co-director of Stanford University’s Primary Care for Cancer Survivorship Program, author, and science journalist, returns to continue our discussion from November 9 about our fragmented health system and what can be done about it.
M2 Jeff Goddard, M1s Fallon Jung and Alex Nigg, and MD/PhD student Jacquelyn Nielson talk with her about what’s missing from the medical safety nets that help low SES patients get emergency care, what kind of AI we really need to bind pieces of of the system together (hint: AIs that offer differential diagnoses and othe...
2023-12-1458 min
The Local Maximum with Max SklarEp. 305 - Fragmented: Health Care and Data with Ilana YurkiewiczToday's guest is Ilana Yurkiewicz, author of Fragmented: A Doctor's Quest to Piece Together American Health Care. The conversation starts with our health data, but goes into practical advice for patients and doctors. Get full access to The Local Maximum at localmaximum.substack.com/subscribe
2023-11-2836 minThe Short Coat: An Inside Look at Getting Into and Getting Through Medical SchoolPiecing Together American Healthcare, Ft. Dr. Ilana Yurkiewicz (Part 1)We have GOT to get it together
What’s the best way to navigate a fragmented healthcare system? How are patients both the victims and unwitting custodians of their own medical stories? And can primary care address gaps in long-term cancer treatment? We had a fun conversation with Dr. Ilana Yurkiewicz, the author of ‘Fragmented, A Doctor’s Quest to Piece Together American Healthcare.’ Jeff, Fallon, AJ, and Alex walked away not only enlightened about the gaps in the contemporary healthcare system but also the importance of primary care and specialists working together to build patient relationships and keep clinical informat...
2023-11-0947 minMoral MattersFragmented | S7: E1 | Ilana Yurkiewicz, MDIlana Yurkiewicz is a primary care internist and oncologist who recently published a very personal book about the perils of our unintentionally fragmented health care systems. She talks about her journey to this work, and how we all - patients and clinicians - can help reduce the gaps in our medical stories.
Link to Fragmented: https://a.co/d/0Qy6As1
To support the podcast: https://www.fixmoralinjury.org/get-started
Twitter - @fixmoralinjury
Instagram - @moralinjury
Facebook - @moralinjuryofhc
LinkedIn - @moral Injury of Healthcare
2023-09-1442 min
Get Top-Rated Audiobook Collection for Your LibraryIlana Yurkiewicz MD - FragmentedPlease visit https://thebookvoice.com/podcasts/2/audible/23980 to listen full audiobooks.
Publisher's Summary: There's an unspoken assumption when we go to see a doctor: the doctor knows our medical story and is making decisions based on that story. But reality often falls short. Medical records vanish when we switch doctors. Critical details of life-saving treatment plans get lost in muddled electronic charts. The doctors we see change according to specialty, hospital shifts, or an insurer's whims. In this gripping narrative from medicine's front lines, Ilana Yurkiewicz reveals how a system that doesn't talk to itself puts insupportable burdens on physicians...
2023-09-067h 29
Searching for Medicine’s SoulIlana Yurkiewicz on the Broken State of American HealthcareIn this episode of Searching for Medicine’s Soul, Aaron was joined by Dr. Ilana Yurkiewicz, a physician practicing oncology and internal medicine at Stanford University, published medical journalist, and author of Fragmented: A Doctor’s Quest to Piece Together American Health Care. Aaron and Ilana discuss how America’s healthcare system functions in a way that blocks physicians from possessing complete knowledge of a patient’s medical history, and the detrimental effects of physicians being partially blindfolded as they practice.
2023-08-171h 19
Health After CancerFinding a Doctor After Cancer: A Conversation with Ilana YurkiewiczIn this Episode
Notes coming soon!
Find out more at https://health-after-cancer.pinecast.co
2023-08-0119 min
Healthcare UnfilteredEpisode 140: Fixing Fragmented Healthcare With Ilana YurkiewiczIlana Yurkiewicz, MD, medical oncologist and primary care physician with a focus on cancer patients, and esteemed author of the book “Fragmented: A Doctor's Quest to Piece Together American Health Care,” joins the show as today’s guest of honor. Chadi and Dr. Yurkiewicz discuss her unorthodox career path and inspiration to write the book, where the fragmentation within the healthcare system can be pinpointed (layers upon layers), the many narratives and original research she adds to the book to make the story relatable and compelling, and the low-hanging fruit that can change the system for the better, among many o...
2023-07-2559 min
Talk Nerdy with Cara Santa MariaFragmented Healthcare w/ Ilana YurkiewiczIn this episode of Talk Nerdy, Cara is joined by Dr. Ilana Yurkiewicz, oncologist, internal medicine physician, and professor at Stanford University. They talk about her new book, "Fragmented: A Doctor's Quest to Piece Together American Healthcare," with a special emphasis on patient advocacy, continuity of care, and potential solutions to a broken managed care system.
2023-07-241h 10
It's about the triple aim!Meet Ilana Yurkiewicz MD, Author: Fragmented MedicineThere’s an unspoken assumption when you go to see a doctor: the doctor knows your medical story and is making decisions based on that story. But the reality frequently falls short. Medical records vanish when we switch doctors. Critical details of life-saving treatment plans get lost in muddled electronic charts. The doctors we see change according to specialty, hospital shifts, or an insurer’s whims.
Stanford physician Ilana Yurkiewicz calls this fragmentation, and, she reveals, it’s the central failure of health care today. In this gripping narrative from medicine’s front lines, she shows how a system that doesn’t...
2023-07-1930 min
Blood & CancerPatient anxiety, social support, optimism bias, and 'How long do I have left?': The best-of Dr. Ilana Yurkiewicz Ilana Yurkiewicz, MD, recorded dozens of Clinical Correlation segments for Blood & Cancer for more than a year. She also hosted a three-part series on difficult conversations that trainees have with their patients. In this episode, we revisit the best of Dr. Yurkiewicz. 'How long do I have left?' 02:59 Anxiety 17:02 Optimism Bias 20:21 Social Support 23:51 Family Dynamics 26:07 For more MDedge Podcasts, go to mdedge.com/podcasts Email the show: podcasts@mdedge.com Interact with us on Twitter: @MDedgehemonc David Henry on Twitter: @davidhenrymd
2020-07-0229 minBlood & CancerAn internist’s experience with COVID-19In this episode, Matthew Watto, MD, an internist at Pennsylvania Hospital in Philadelphia, tells host David H. Henry, MD, also of Pennsylvania Hospital, how the COVID-19 pandemic has affected him personally and professionally. Dr. Watto recounts how COVID-19 has impacted patient volume, shifts, teaching, and interactions between patients and staff. Dr. Watto also discusses his internal medicine podcast, The Curbsiders, which, he says, provides listeners with “clinical pearls, practice-changing knowledge, and bad puns.” Disclosures: Dr. Henry has no financial disclosures relevant to this episode. Dr. Watto has no financial disclosures relevant to this epis...
2020-05-1431 minBlood & CancerTreating genitourinary malignancies in the COVID-19 eraHow should oncologists be treating genitourinary malignancies during the COVID-19 pandemic? Aly-Khan A. Lalani, MD, of McMaster University in Hamilton, Ontario, and colleagues recently published recommendations that help answer that question (Can Urol Assoc J. 2020 May;14[5]:e154-8). In this episode, Dr. Lalani reviews some of these recommendations with podcast host David H. Henry, MD, of Pennsylvania Hospital in Philadelphia. The pair discuss when and how to use androgen receptor axis-targeted therapies and radium-223 in metastatic prostate cancer, platinum-based chemotherapy in advanced urothelial carcinoma, and checkpoint inhibitors in patients with urothelial carcinoma or renal cell carcinoma.
2020-05-0734 minBlood & CancerThe first virtual ASCO meeting; plus Part 2 of tech tools for docsThe American Society of Clinical Oncology is gearing up for its first-ever virtual meeting at the end of May 2020. ASCO’s president Howard A. “Skip” Burris, III, MD, joins David H. Henry, MD, of Pennsylvania Hospital, Philadelphia, to explain how the virtual meeting will work, from releasing research to earning continuing medical education credits. Dr. Burris also explores how the society is responding to COVID-19. Later in the podcast, Bernard A. Mason, MD, an oncologist with Pennsylvania Hospital and the University of Pennsylvania, both in Philadelphia, is back with some bonus technology tips for taking notes and syncin...
2020-04-3037 minBlood & CancerTreating colorectal cancer in the COVID-19 eraOncologists are now weighing the benefits of treating cancer patients against the risk of exposing them to SARS-CoV-2. David Kerr, MD, DSc, of University of Oxford (England) talks with podcast host David H. Henry, MD, of Pennsylvania Hospital in Philadelphia, about how to treat colorectal cancer patients in the COVID-19 era. Dr. Kerr cowrote an article on MDedge Hematology/Oncology that outlined recommendations for treating colorectal cancer patients during the pandemic. In this episode, Dr. Henry and Dr. Kerr review those recommendations and compare notes on U.K. and U.S. practices. Disclosures: ...
2020-04-2339 minBlood & CancerCOVID-19 and the community oncologistHow are community oncologists adapting to the COVID-19 pandemic? Podcast host David H. Henry, MD, of Pennsylvania Hospital in Philadelphia, explores this question with Matthew Lonergan, MD, of Willamette Valley Cancer Institute (WVCI) and Research Center in Eugene, Ore. Dr. Lonergan explains how WVCI is attempting to minimize staff exposure to COVID-19, how physicians there are dealing with the transition to telemedicine, and how a lack of resources has affected WVCI. Dr. Lonergan and Dr. Henry also discuss how the COVID-19 pandemic has changed research, tumor boards, and other meetings. And the pair compare the response to...
2020-04-1638 minBlood & CancerCOVID-19 and lung cancer: The decision to delay treatmentIn the “new normal” of treating cancer patients during COVID-19, when do you decide to start treatment or pause it? Narjust Duma, MD, a thoracic oncologist at the University of Wisconsin, Madison, shares how she makes those decisions in partnership with her lung cancer patients and how the discussions are complicated by the fear and uncertainty around the pandemic. Later in the podcast, Dr. Duma and podcast host David H. Henry, MD, of Pennsylvania Hospital, Philadelphia, explore how telehealth changes patient encounters, use of liquid biopsies to keep patients out of the hospital, and the importance of chec...
2020-04-0933 minBlood & CancerCOVID-19: ‘The world has changed’Zainab Shahid, MD, medical director of bone marrow transplant infectious diseases at the Levine Cancer Institute/Atrium Health in Charlotte, N.C., breaks down when cancer patients should seek testing for COVID-19 and how they should be treated. Dr. Shahid also compares notes with Blood & Cancer host David H. Henry, MD, of Pennsylvania Hospital in Philadelphia, on how the COVID-19 pandemic has changed the world of medical education. In Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, celebrates National Doctors Day amid the COVID-19 pandemic. Topics covered in this podcast: How the education...
2020-04-0231 minBlood & CancerGrands rounds in the age of COVID-19; cardiotoxicity in breast cancerSusan Dent, MD, codirector of the cardio-oncology program at Duke University in Durham, N.C., reflects on virtual grand rounds, telehealth, the screening of patients before clinic visits, and other new realities of cancer care in the age of COVID-19. Dr. Dent also discusses the importance of assessing breast cancer patients for cardiotoxicity. In Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, talks about the importance of advance directives. * * * Cardiotoxicity in breast cancer treatment HER2 drugs (such as trastuzumab) and conjugates If given appropriately, these drugs have limited cardiotoxicity. The...
2020-03-2632 minBlood & CancerTech tools for docs: Apps, sites, and software in the virtual worldDavid Henry, MD, welcomes Bernard A. Mason, MD, to discuss Dr. Mason's favorite digital tools for working as a physician in part 1 of 2. Dr. Mason is an oncologist with the Pennsylvania Hospital and the University of Pennsylvania, both in Philadelphia. Dr. Mason explains the actual benefits for doctors and health care providers for popular apps and services from storage to maps. He and Dr. Henry explore the following: One drive Google Drive Google Photos Google Maps Offline HERE WeGo This week's installment of Clinical Correlation, Ilana Yurkiewicz, MD, poses a complicated question about o...
2020-03-1932 minBlood & CancerCommon bleeding and coagulation issuesThere’s an art to taking a thorough bleeding history. In this episode, Adam Cuker, MD, director of the Hemophilia and Thrombosis Center at the University of Pennsylvania, Philadelphia, shares the most important questions to ask and the challenges in assessing risk in patients about to undergo surgery and those with active bleeding. In Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, talks about delivering good news to patients. Practice points: Always take a thorough bleeding history. Ask patients about bleeding from head to toe. Even if the basic laboratory evaluation is normal, the...
2020-03-1230 minBlood & CancerIs this a good study? The statistics tell the storyEver read through a study and wondered how to apply the hazard ratio, or if you should change your practice because of a secondary endpoint finding? In this episode, Lauren M. Catalano, MD, of the University of Pennsylvania, Philadelphia, explains all the common terms and why they matter in the context of the KEYNOTE-024 trial. In Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, talks about how to prepare for an unexpected bad outcome. Practice points: Don’t skip over the statistical analysis portion of a paper. Use Google to find simple definitions for...
2020-03-0531 minBlood & CancerTreatment approaches in AMLA diagnosis of acute myeloid leukemia (AML) was once an emergency, requiring immediate treatment. Today, the need to start treatment is still urgent, but many patients can benefit by waiting a few days for testing to reveal a fuller picture of the disease. That’s the advice of James M. Foran, MD, of the Mayo Clinic. He joins Blood & Cancer host David H. Henry, MD, of the Pennsylvania Hospital, Philadelphia, to walk through some patient scenarios and the newest treatment options. In Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, talks about what patients do and do...
2020-02-2732 minBlood & CancerTreatment tips in CLLThe million-dollar question in the treatment of chronic lymphocytic leukemia (CLL) is what to do after a patient relapses following treatment with venetoclax. Anthony Mato, MD, and Lindsey Roeker, MD, both of Memorial Sloan Kettering in New York, join podcast host David H. Henry, MD, of Pennsylvania Hospital, Philadelphia, to explore the evidence about this question and to review the initial patient work-up and treatment strategies. In Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, discusses patients compliance and how clinician biases can influence compliance. Practice points: For patients with CLL with unmutated...
2020-02-2022 minBlood & CancerWhen to refer for CAR T-cell therapyChimeric antigen receptor (CAR) T-cell therapy is one of the hottest advances in lymphoma treatment, but who should get it and what does the process look like? Allison Winter, MD, of the Cleveland Clinic helps answer those questions on the podcast. She joins Blood & Cancer host David H. Henry, MD, of the Pennsylvania Hospital, Philadelphia, to break down the side effects and look ahead to possible off-the-shelf products. In Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, discusses optimism bias. She recalls a time when a patient’s drive for optimism affected what she told them an...
2020-02-1321 min
Blood & CancerUnderstanding biosimilarsThink of biosimilars as your mother’s minestrone soup: It’s the same recipe and ingredients every time, but not every batch is chemically identical, even if it tastes about the same. That’s how Brian T. Hill, MD, PhD, of the Cleveland Clinic, describes biosimilars. He joins Blood & Cancer host David H. Henry, MD, of Pennsylvania Hospital, Philadelphia, to discuss how biosimilars are made and approved, and how they differ from generic drugs. In Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, talks about percentages -- what they mean, what they don’t mean, and how they...
2020-02-0619 minBlood & CancerASH19 special reportBlood & Cancer takes you behind the podium at the American Society of Hematology annual meeting for an in-depth look at the latest developments in anemia and myelodysplastic syndrome, chimeric antigen receptor (CAR) T-cell therapy for mantle cell lymphoma, use of novel agents in follicular lymphoma, and a range of new advances being explored in chronic lymphocytic leukemia. Guests on the podcast include Brian T. Hill, MD, PhD, and Allison Winter, MD, both with the Cleveland Clinic, and Anthony Mato, MD, and Lindsey E. Roeker, MD, of Memorial Sloan Kettering Cancer Center in New York. Plus...
2020-01-3030 minBlood & CancerSickle cell update: Treating pain and progress toward cureWhen it comes to treating pain related to sickle cell disease, consider the underlying factors, from constipation to compression spine deformity. That’s just some of the advice from Ifeyinwa Osunkwo, MD, of Atrium Health and Levine Cancer Institute in Charlotte, N.C. She joins host David H. Henry, MD, of Pennsylvania Hospital, Philadelphia, to discuss her tips for treating pain and other complications of sickle cell disease. Dr. Osunkwo also provides an update on progress toward a cure in sickle cell disease that could be available to a large number of patients. Plus, in Clinical Correlation, Il...
2020-01-2325 min
Blood & CancerPractice-changing research in GI cancerDaniel G. Haller, MD, of the University of Pennsylvania, Philadelphia, joins Blood & Cancer host David H. Henry, MD, also of the University of Pennsylvania, to review the top three GI cancer trials presented at the 2019 ESMO World Congress on Gastrointestinal Cancer, and how they are changing practice. Plus, in Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, talks about the difficulty in using age to guide cancer treatment. * * * BEACON trial for colorectal cancer Patients with BRAF mutations have a poor prognosis and typically fail treatment prior to second line therapy. BEACON is a...
2020-01-1624 minBlood & CancerPalliative care: Not just another word for hospiceThomas LeBlanc, MD, of Duke Cancer Institute in Durham, N.C., joins host David H. Henry, MD, of Pennsylvania Hospital, Philadelphia, to discuss the evolution of the palliative care field and some of the underrecognized ways that it can improve care for hematology-oncology patients. Plus, in Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, shares the story of a patient who put aside her own desire for hospice because of family pressure to pursue curative treatment. * * * Palliative medicine has evolved tremendously over the past decade; it used to be synonymous with hospice and dy...
2020-01-0934 min
Blood & CancerThe best of Clinical CorrelationIn this special edition podcast, we bring you the best of Clinical Correlation, a segment on the human side of hematology-oncology care. Clinical Correlation is written, recorded, and produced by Ilana Yurkiewicz, MD, of Stanford (Calif.) University. This episode includes five of our favorite Clinical Correlation segments. For more MDedge Podcasts, go to mdedge.com/podcasts Email the show: podcasts@mdedge.com Interact with us on Twitter: @MDedgehemonc David Henry on Twitter: @davidhenrymd Ilana Yurkiewicz on Twitter: @ilanayurkiewicz
2020-01-0215 min
Blood & CancerICYMI: Get to know Dr. Ilana YurkiewiczIn this special edition podcast, Blood & Cancer revisits an interview with Ilana Yurkiewicz, MD, of Stanford (Calif.) University. Dr. Yurkewicz is the writer and producer of the podcast’s Clinical Correlation segment, which puts a human face on hematology-oncology care. She sits down with MDedge producer Nick Andrews for a wide-ranging interview that covers everything from the best advice she’s ever gotten to her favorite science fiction writer. The interview first aired on our sister podcast, Postcall. For more MDedge Podcasts, go to mdedge.com/podcasts Email the show: podcasts@mdedge.com
2019-12-2636 min
Blood & CancerASCO president on uniting the oncology fieldHoward “Skip” Burris, MD, chief medical officer of Sarah Cannon Cancer Institute in Nashville, Tenn., joins the podcast to talk about what it’s like to be the 2019-2020 president of the American Society of Clinical Oncology. Dr. Burris joins Blood & Cancer host David H. Henry, MD, of Pennsylvania Hospital, Philadelphia, to share his priorities as president and how he finds the time for advocacy, research, and clinical practice. Plus, in Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, shares the story of a couple who had cancer at the same time. For mor...
2019-12-1922 minBlood & Cancer2019 drug approvals in hematology-oncologyDavid Mintzer, MD, of the University of Pennsylvania, Philadelphia, joins the podcast to discuss noteworthy drug approvals in hematology-oncology in 2019. Dr. Mintzer and Blood & Cancer host, David H. Henry, MD, of Pennsylvania Hospital, Philadelphia, discuss what these new treatment options mean for clinicians and patients. Plus, in Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, is at the annual meeting of the American Society of Hematology with a reminder that the way we talk about patients matters. * * * Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r...
2019-12-1221 minBlood & CancerASH 2019 Preview: Potentially practice-changing studiesMatt Kalaycio, MD, of the Cleveland Clinic joins Blood & Cancer host David H. Henry, MD, of Pennsylvania Hospital, Philadelphia, to preview the potentially practice changing research that will be reported at the 2019 annual meeting of the American Society of Hematology. Plus, in Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, addresses the isolation that comes from dealing with a serious chronic illness, especially around the holidays. * * * Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019 * * * FDA approves atezolizumab combo as firs...
2019-12-0539 minBlood & CancerBreaking down biosimilars: ICYMIIn this special edition podcast, Blood & Cancer revisits an interview with Gary H. Lyman, MD, of Fred Hutchinson Cancer Research Center, Seattle, on defining and understanding biosimilars. Dr. Lyman joins host David H. Henry, MD, to explore the interchangeability of these drugs and how biosimilars are being integrated into clinical practice guidelines. * * * Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019 * * * This Week in Oncology ASH preview: Key themes include tackling CAR T obstacles, sickle cell advances, VTE By Sharon...
2019-11-2828 min
Blood & CancerBreast cancer case review with Dr. Jame Abraham Jame Abraham, MD, of the Cleveland Clinic joins Blood & Cancer host David H. Henry, MD, of Pennsylvania Hospital, Philadelphia to review two cases of breast cancer, focusing on when to use the 21-gene Oncotype DX breast recurrence score and how to apply the results. Plus, in Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, explores what happens when the patient minimizes their symptoms in order to keep getting treatment. * * * Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019 * * * This Week in...
2019-11-2129 min
Blood & CancerImmunotherapy in lung cancer with Dr. Jack West, Part 2Jack West, MD, joins the podcast to discuss the immunotherapy in the treatment of lung cancer. Dr. West is an associate clinical professor in medical oncology at City of Hope Comprehensive Cancer Center in Duarte, Calif., and a thought leader in thoracic oncology. Dr. West and Blood & Cancer host David H. Henry, MD, of Pennsylvania Hospital, Philadelphia, discuss assays, liquid biopsy, and review a recent case in part two of their interview. Plus, in Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, reminds us that even when just “covering” a patient for another physician, you could be i...
2019-11-1428 min
Blood & CancerImmunotherapy in lung cancer with Dr. Jack West, Part 1 H. Jack West, MD, joins the podcast to discuss the latest trials of immunotherapies in the treatment of lung cancer. Dr. West is an associate clinical professor in medical oncology at City of Hope Comprehensive Cancer Center in Duarte, Calif., and a thought leader in thoracic oncology. Dr. West and Blood & Cancer host David H. Henry, MD, of Pennsylvania Hospital, Philadelphia, review Keynote-042, Keynote-189, and IMpower150, and discuss how the findings influence practice. You can find Dr. West on Twitter at @JackWestMD. Plus, in Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, d...
2019-11-0729 min
Blood & CancerReader beware: Interpreting post hoc analysesDavid L. Streiner, PhD, of McMaster University, Hamilton, Ont., and the University of Toronto, joins Blood & Cancer host David Henry, MD, of Pennsylvania Hospital, Philadelphia, to explain what a post hoc analysis is and why it should be interpreted with caution. Plus, in Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, explores what to tell patients when it comes to prognostic scoring system results. * * * Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019 * * * This week in Oncology: ...
2019-10-3122 min
Blood & CancerDelivering bad news to patientsStrategies and guidelines for delivering bad news to patients from David Henry, MD, and Ilana Yurkiewicz, MD. Timestamps: This week in Oncology (01:30) Conversation (04:22) This week, the host of Blood & Cancer and the writer, producer, and talent behind the Clinical Correlation segment sit down together for the first time ever. Dr. Henry and Dr. Yurkiewicz share strategies and anecdotes about their experiences learning how to give patients terrible news and --perhaps more importantly -- how not to. Links: SPIKES mnemonic Dr. Henry: Academic Biography Dr. Yurkiewicz Academic Biography Hard Questions column T...
2019-10-2426 min
Blood & CancerChoosing a melanoma therapy with Dr. Justine CohenJustine V. Cohen, DO, of the University of Pennsylvania, Philadelphia, joins Blood & Cancer host David H. Henry, MD, also of the University of Pennsylvania, to discuss a recent melanoma case in the adjuvant setting and when to consider targeted therapies or immune checkpoint inhibitors for these patients. Plus, in Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, talks about what happens when a patient’s anxiety threatens to get in the way of the clinician’s decision making. Time stamps: Meet the guest (00:51) This Week in Oncology (03:02) Interview with Dr. Justine Cohen (05:48) Clinical Corre...
2019-10-1730 min
Postcall PodcastDrinking before a shift and hard patient conversationsIn episode 51, Nick and Emi Okamoto, MD, discuss what makes a good doctor-patient relationship, how EMRs affect burnout, and when, if ever, it's okay to have had a drink before a clinical shift. The interview portion of this episode comes from Ilana Yurkiewicz, MD, who hosts a discussion about difficult conversations that residents and fellows need to have with their patients. Dr. Yurkiewicz, along with Emily Bryer, DO, and Ronak Mistry, DO, address those times when a patient asks what you would do if the patient were your family member, and how much patients really want to k...
2019-10-1132 min
Blood & Cancer'What would you do if this were your family member?'In this edition, we conclude our 3-part series about having hard conversations with patients as a trainee. This week's case poses the following question: "What would you do if this were your family member?" Ilana Yurkiewicz, MD, Blood & Cancer cohost and producer of the Clinical Correlation segment, is joined by the two residents who have been behind the Blood & Cancer show notes from the beginning, Emily Bryer, DO, and Ronak Mistry, DO, both of the University of Pennsylvania, Philadelphia. David H. Henry, MD, editor in chief of MDedge Hematology-Oncology and the host of Blood & Cancer...
2019-10-1024 min
Blood & CancerEnding curative therapy even when the family wants itHematology/oncology requires clinicians to have some of the most difficult conversations in all of medicine. In part 2 of our 3-part series, we tackle how to talk about ending curative therapy even when the family wants to keep going. These conversations are hosted by Ilana Yurkiewicz, MD, the host and producer of the Clinical Correlation segment and the author of Hard Questions, a monthly column at MDedge Hematology-Oncology. She is joined by the two residents who have been behind the Blood & Cancer show notes from the beginning, Emily Bryer, DO, and Ronak Mistry, DO, both of the Un...
2019-10-0318 min
Blood & Cancer'How long do I have left?' Difficult conversations for trainees (part 1)Hematology/oncology requires clinicians to have some of the most difficult conversations in all of medicine. In this edition, we begin a three-part series about having those conversations. These conversations will be hosted by Ilana Yurkiewicz, MD, the host and producer of the Clinical Correlation segment and the author of Hard Questions, a monthly column at MDedge Hematology-Oncology. She is joined by the two residents who have been behind Blood & Cancer show notes from the beginning, Emily Bryer, DO, and Ronak Mistry, DO, both of the University of Pennsylvania, Philadelphia. David H. Henry, MD, editor in...
2019-09-2621 min
Blood & CancerUpdated ASCO guidelines for VTE in cancer Alok Khorana, MD, of the Cleveland Clinic joins Blood & Cancer host David H. Henry, MD, of Pennsylvania Hospital, Philadelphia, to break down the latest recommendations from the American Society of Clinical Oncology on venous thromboembolism (VTE) prophylaxis in cancer patients. Plus, in Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, shares her answer to a frequent question from cancer patients: What should I eat? This Week in Oncology What is the role of thromboprophylaxis in patients with cancer in the outpatient setting? Key change in ASCO recommendations: Thromboprophylaxis with apixaban, rivaroxaban, or...
2019-09-1932 min
Blood & CancerCastleman disase: Dr. David Fajgenbaum chases his cureDavid Fajgenbaum, MD, of the University of Pennsylvania, Philadelphia, is a pioneer in the research of Castleman disease and he’s a patient himself. He joins Blood & Cancer host David Henry, MD, of Pennsylvania Hospital, Philadelphia, to talk about the presentation of Castleman, available treatments, and his own patient journey. Plus, in Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, talks about compassion fatigue among friends and family of cancer patients. This Week in Oncology Time Stamps: This week in Oncology (03:51) Interview (07:24) Clinical Correlation (34:15) Show notes Castleman disease is...
2019-09-1237 min
Blood & CancerDecoding the mystery of the meta-analysis David L. Streiner, PhD, of McMaster University, Hamilton, Ont., and the University of Toronto, joins Blood & Cancer host David Henry, MD, of Pennsylvania Hospital, Philadelphia, to talk about meta-analyses and what they really tell us about the evidence for treatment. Plus, in Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, talks about when a second or third opinion can be detrimental in aggressive cancer. This Week in Oncology Show notes Meta-analysis: A systematic, thorough review of the literature, extraction of the effect sizes, and mathematical combination of effect sizes t...
2019-09-0530 min
Blood & CancerGI malignancy case reviewDaniel G. Haller, MD, of the University of Pennsylvania, Philadelphia, joins Blood & Cancer host David H. Henry, MD, also of the University of Pennsylvania, to discuss two real-world gastrointestinal cancer cases and how the latest research should influence the approach to care. Plus, in Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University talks about pressure from patients to overtreat indolent cancer. This week in Oncology: Perceived discrimination linked to delay in ovarian cancer diagnosis for black women Perceived everyday discrimination was associated with an extended duration between symptom onset and cancer diagnosis...
2019-08-2929 min
Blood & CancerASCO 2019 Breast Cancer Update William J. Gradishar, MD, of Feinberg School of Medicine and Northwestern Medicine in Chicago, chats with David H. Henry, MD, host of Blood & Cancer, to review some of the top breast cancer research presented at the 2019 annual meeting of the American Society of Clinical Oncology. Plus, in Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, talks about dealing with help-seeking and help-rejecting patients. Show notes This episode discusses three randomized, controlled phase 3 trials that were presented at ASCO 2019: KRISTINE trial (abstract 500) Design: Patients with HER2-positive breast can...
2019-08-2233 min
Blood & CancerGeriatric oncology David Cella, PhD, of Northwestern University in Chicago, joins Blood & Cancer as the guest host for a conversation with Supriya Mohile, MD, MS, of the University of Rochester in N.Y., on geriatric oncology and the best tools to assess the fitness of older patients with cancer. In Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, talks about social support and what happens when there isn’t a supportive family member at the bedside. Show notes What is “geriatric oncology?” The geriatrics population is traditionally defined as people aged 65 years and older...
2019-08-1534 min
Blood & CancerThe pitfalls of P valuesDavid L. Streiner, PhD, of McMaster University, Hamilton, Ont., and the University of Toronto, joins Blood & Cancer host David Henry, MD, of Pennsylvania Hospital, Philadelphia, to explain what P values actually measure and how they both help and hinder the interpretation of clinical research findings. Plus, in Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, explores how quickly cancer can turn into bankruptcy. Show notes In statistics, P value is null hypothesis significance testing. The P value assesses the following: If the null hypothesis (i.e., there is no difference) is true, what...
2019-08-0830 min
Blood & CancerCancer trials in the communityEdward S. Kim, MD, of Levine Cancer Institute at Atrium Health in Charlotte, N.C., chats with David H. Henry, MD, host of Blood & Cancer, about how to perform clinical trials in the community oncology setting. Plus, in Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, discusses a byproduct of our fragmented health care system – patients having to hear the same bad news repeated over and over. Show notes Only 3%-4% of adult oncology patients are enrolled in clinical trials. Most patients diagnosed with cancer are seen in community settings (as opposed to aca...
2019-08-0135 min
Blood & CancerPolypharmacy in older cancer patients Ginah Nightingale, PharmD, of the Jefferson College of Pharmacy at Thomas Jefferson University in Philadelphia chats with David H. Henry, MD, host of Blood & Cancer, about the definition of polypharmacy and the challenges it poses in treating older cancer patients. Plus, in Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, talks about the waiting that cancer patients face. Show notes Older adults comprise about 15% of the total population but account for more than 33% of prescription drug use. Polypharmacy can be defined as taking five or more medications (prescription and nonprescription), as well as...
2019-07-2532 minBlood & CancerPancreatic cancer and clinical trialsPancreatic cancer and clinical trials David H. Henry, MD, host of Blood & Cancer, is on location at the 2019 annual meeting of the American Society of Clinical Oncology during this podcast, speaking with Davendra Sohal, MD, of the Cleveland Clinic. Dr. Sohal presented preliminary results from SWOG S1505, a phase 2 study on neoadjuvant chemotherapy for resectable pancreatic adenocarcinoma. Plus, in Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, talks about what happens when a cancer patient wants to act against medical advice. Show Notes By Emily Bryer, DO, resident i...
2019-07-1724 min
Blood & CancerFinancial toxicity of cancerDavid H. Henry, MD, host of Blood & Cancer, is joined by two experts on the financial toxicity of cancer. Melissa Monak and Kimberly Bell, both of the Cleveland Clinic, presented research at the 2019 annual meeting of the American Society of Clinical Oncology on the implementation of a financial navigation program at the Cleveland Clinic’s Taussig Cancer Center. In this podcast, they discuss the findings of their research and how just educating patients about their insurance benefits can improve access and patient satisfaction. Plus, in Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, revisits the “illusion of op...
2019-07-1124 min
Blood & CancerBloodless medicine, iron deficiency, and ASCO reflectionsEpisode 24: David H. Henry, MD, host of Blood & Cancer, is on location at the 2019 annual meeting of the American Society of Clinical Oncology in this podcast. Dr. Henry speaks with one of his own residents, Ronak Mistry, DO, about recent research among “bloodless medicine” patients, iron deficiency, and the ASCO experience. Plus, in Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, talks about what happens when patients do their own literature search for treatment options. Show notes By Emily Bryer, DO, resident in the department of intern...
2019-06-2721 min
Blood & CancerWelcome to CancerlandEpisode 22: David Scadden, MD, of Harvard University Medical School, Boston, joins Blood & Cancer host David H. Henry, MD, of the University of Pennsylvania, Philadelphia, for a conversation about his book, “Cancerland: A Medical Memoir,” as well as immunotherapy and the challenge of patient care in the EHR age. Plus, in Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University talks about enrolling patients in clinical trials and the tension between their needs and the goals of research. Read more about Dr. Scadden’s research: http://www.scaddenlab.com/ Read more about Cancer...
2019-06-2039 min
Blood & CancerPatient-reported outcomes in cancer: Episode 21 David Cella, PhD, of Northwestern University in Chicago, joins Blood & Cancer as the guest host for a conversation on patient-reported outcomes and how to apply them in oncology clinical practice with Ethan Basch, MD, of the University of North Carolina, Chapel Hill. In Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, talks about invisible illness and what it’s like for a patient to be dying but appear outwardly healthy. Show notes By Emily Bryer, DO, resident in the department of internal medicine, University of Pennsylvania, Philadelphia Patients understand how t...
2019-06-1330 min
Blood & CancerAsk about constipation: Ep 20James C. Reynolds, MD, of the University of Pennsylvania, Philadelphia, joins Blood & Cancer host David H. Henry, MD, also of the University of Pennsylvania, to discuss the ins and outs of constipation among cancer patients: how to recognize it, how to treat it, and why you need to ask about it. Plus, in Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University talks about those tough phone calls. You can interact with the show on Twitter: @DavidHenryMd @IlanaYurkiewicz @MDedgeHemOnc Show notes By Emily Bryer, DO...
2019-06-0635 min
Blood & CancerBONUS: Get to know Ilana Yurkiewicz, MDIn this bonus edition, MDedge Postcasts voice Nick Andrews brings an interview from our sister show, the Postcall Podcast with Ilana Yurkiewicz, MD. You can learn more about the Postcall Podcast by clicking here. Ilana Yurkiewicz, MD, is a hem/onc fellow at Stanford. She writes the Hard Questions Column for MDedge Hematology/Oncology and writes/records/produces the Clinical Correlation segment of Blood & Cancer, the official podcast of MDedge Hematology/Oncology. Dr. Yurkiewicz's 's articles: Doctor will you please lie to me? Should doctors disclose primary re...
2019-06-0436 min
Postcall PodcastSchedule problems: helping your family, friends to get it Nick and Emi Okamoto, MD, take the weekly quiz, Dr. Emi gives advice for talking to your friends and family about your crazy schedule, and can you tell if it's advice for residents or advice for newlyweds? Time stamps: MDedge Quiz (02:09) Advice Game: Newlyweds or Residents? (06:45) This week in MedTwitter (09:46) How to participate in holidays when you're working/can't make it (10:58) "I feel, I think, I want," educating your family (11:55) Health equity (13:33) Interview Intro (15:27) Interview with Ilana Yurkiewicz, MD. 18:15) Meet Dr. Yurkiewicz: family, hobbies, etc. (31:06) What Dr. Yurkiewicz reads, Ted Cheng - Story of...
2019-05-3150 min
Blood & CancerCancer-related fatigue David Cella, PhD, and Lisa Wu, PhD, both of Northwestern University in Chicago, discuss fatigue and sleep disturbance related to cancer – its prevalence and possible treatments -- in this episode of Blood & Cancer. In Clinical Correlation (29:45), Ilana Yurkiewicz, MD, of Stanford (Calif.) University, shares a case that highlights the resilience that patients show in the face of cancer, and asks: Can a positive attitude improve outcomes? Show notes By Hitomi Hosoya, MD, PhD, resident in the department of internal medicine, University of Pennsylvania, Philadelphia Cancer-related fatigue is pre...
2019-05-3033 min
RoS: Review of SystemsRoS: Barriers to accessing medical records for patients & providers, and how that harms careHow long have we all, collectively in healthcare, spent on hold with medical records departments, listening to mind-numbing muzac or assembled around the fax machine, waiting for your patient’s crucial imaging reports or culture results from another hospital to come through? Way too long. Difficulty accessing medical records can be extremely difficult, which we explore today with two guests. Ilana Yurkiewicz is a physician and writer, and recently published an article on Undark, entitled Paper Trails: Living and Dying with Fragmented Medical Records, which explores how poor communication of medical records resulted in harm to one of her pa...
2019-05-2700 min
Blood & CancerHazard ratio? P value? What statistics mean in practiceEpisode 17: David L. Streiner, PhD, of McMaster University, Hamilton, Ont., and the University of Toronto, joins Blood & Cancer host David Henry, MD, of Pennsylvania Hospital, Philadelphia, to talk hazard ratios and P values as they examine the clinical relevance of findings from a phase 3 trial. In Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, talks about how to balance family versus patient preferences. Show notes By Emily Bryer, DO, resident in the department of internal medicine, University of Pennsylvania, Philadelphia A phase 3 trial is a ran...
2019-05-2327 min
Blood & CancerLung cancer: PD, PDL-1, and immunotherapyHoward “Skip” Burris, MD, the chief medical officer of Sarah Cannon Cancer Institute in Nashville, Tenn., joins the podcast as the guest host for a discussion of PD1 and PDL1 in the treatment of lung cancer. Dr. Burris interviews Melissa Johnson, MD, the associate director of lung cancer research at Sarah Cannon. Plus, in Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University dives into the financial realities of cancer care. Show notes By Emily Bryer, DO, resident in the department of internal medicine, University of Pennsylvania, Philadelphia Programmed death ligand...
2019-05-1635 min
Blood & CancerITP: When and how, pregnant patientsEpisode 15 Host David Henry, MD, welcomes David J. Kuter, MD, of Harvard and Massachusetts General Hospital to talk about idiopathic thrombocytopenic purpura. He answers questions like: what are the causes? When do you treat? In Clinical Correlation this week, Ilana Yurkiewicz, MD, explores pregnant patients. Show notes By Hitomi Hosoya, MD, PhD, resident in the department of internal medicine, Pennsylvania Hospital of the University of Pennsylvania Health System, Philadelphia Causes of idiopathic thrombocytopenic purpura : Secondary causes include chronic lymphocytic leukemia, lymphoma, and autoimmune conditions and a...
2019-05-0931 min
Blood & CancerASCO GI 2019Daniel G. Haller, MD, of the University of Pennsylvania, Philadelphia, joins Blood & Cancer host David H. Henry, MD, also of the University of Pennsylvania, to review the top research presented at ASCO GI 2019. Plus, in Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University shares the story of a patient who had no questions about the details of his treatment but needed answers about the “big picture.” Show Notes By Emily Bryer, DO, resident in the department of internal medicine, University of Pennsylvania, Philadelphia Phase 2 trial of pembrolizumab (Keytruda), chemot...
2019-04-2521 min
Blood & CancerDrug development stats and researchStatistics 101 for the oncologist Episode 12: David L. Streiner, PhD, of McMaster University and the University of Toronto, joins Blood & Cancer host David Henry, MD, of Pennsylvania Hospital, Philadelphia, to break down the basic statistics knowledge that doctors need – but may not have – to understand and contextualize research findings. In Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University talks about reclaiming the term “sorry.” Dr. Yurkiewicz writes a regular column for Hematology News, which you can find by clicking here. Show notes By Emily Brye...
2019-04-1826 min
Blood & CancerAnemia in cancer You can contact Blood & Cancer at podcasts@mdedge.com and you can follow MDedge Hematology Oncology on Twitter @MDedgeHemOnc. Episode 11: Blood & Cancer host David Henry, MD, welcomes John Glaspy, MD, to talk about anemia in cancer. And in today's Clinical Correlation, Ilana Yurkiewicz, MD, talks apathy. Dr. Yurkiewicz has a column at MDedge, which you can find by clicking here. Show notes By Emily Bryer, DO, resident in the department of internal medicine, University of Pennsylvania Hemoglobin is associated with quality of life and func...
2019-04-1127 min
Blood & CancerBreast Cancer, CDK4/6 InhibitorsWe'd love to hear from you with ideas, suggestions, feedback, and questions for Dr. Henry or Dr. Yurkeiwicz at podcasts@mdedge.com and you can follow MDedge Hematology/Oncology at @MDedgeHemOnc. Blood & Cancer episode 10:CDK4/6 inhibitors in breast cancer Richard Finn, MD, of the Geffen School of Medicine at UCLA joins guest host Jame Abraham, MD, of the Cleveland Clinic to discuss CDK4/6 inhibitors in the treatment of breast cancer, from the first pivotal studies to efficacy and patient selection. Later, Ilana Yurkiewicz, MD, talks about why it’s problematic to t...
2019-04-0430 min
Blood & CancerSickle Cell Treatment, Part IiThe MDedge Daily news is a daily news briefing with the top four stories in clinical medicine news. It's available weekdays at 4:00 a.m. est where ever podcasts are found. Click here to learn more. Blood & Cancer Episode 09: John J. Strouse, MD, PhD, and Julie Kanter, MD, join guest host Ify Osunkwo, MD, of Levine Cancer Institute/Atrium Health in Charlotte, N.C., take a look at some of the thornier issues in sickle cell disease treatment, from caring for young adults to prescribing opioids for pain. Clinical Correlation: Ilana Yurkiewicz, MD, exp...
2019-03-2818 min
Blood & CancerSickle Cell Treatment, Part I: Episode 8: John J. Strouse, MD, PhD, and Julie Kanter, MD, join guest host Ify Osunkwo, MD, of Levine Cancer Institute/Atrium Health in Charlotte, N.C., to discuss current therapies for sickle cell disease, as well as new treatments and cures under development. Clinical Correlations:Ilana Yurkiewicz, MD, tackles informed consent and the capacity to choose in cancer care with a focus on the research setting. Dr. Yurkiewicz is a fellow in hematology and oncology at Stanford University and is a columnist for Hematology News. More from Dr. Yurkiewicz here.
2019-03-2125 min
Blood & CancerLymphoma in Patients w/ HIVStefan K. Barta, MD, of the University of Pennsylvania, joins David Henry, MD, to discuss the treatment and diagnosis of lymphoma in patients with HIV. In this week's Clinical Correlation, Ilana Yurkiewicz, MD, has Part 2 of her discussion on informed consent in cancer. Dr. Yurkiewicz is a fellow in hematology and oncology at Stanford University and is also a columnist for Hematology News. More from Dr. Yurkiewicz here. Notes, Transcripts, Links Show notes By Emily Bryer, DO Resident in the department of internal medicine, University of Pennsylvania. Immunosuppression in patients with HIV, especi...
2019-03-1424 min
Blood & CancerAnticoagulation in cancerWe'd love to hear from you with your ideas, suggestions for topics/guests, shoutouts to colleagues or mentors, questions for Dr. Henry or Dr. Yurkiewizc. To get in touch, please email us at podcasts@mdedge.com or follow us on Twitter @MDedgeHemOnc. In this episode, Alok Khorana, MD, of the Cleveland Clinic joins David H. Henry, MD, to discuss results from the CASSINI trial and what it means for anticoagulation in cancer patients. And Ilana Yurkiewicz, MD, begins part 1 of her look at informed consent. Scroll down for show notes and references ...
2019-03-0730 min
Blood & CancerKATHERINE trial and breast cancerCharles E. Geyer, MD, of Virginia Commonweath University joins guest host Jame Abraham, MD, of the Cleveland Clinic to discuss the KATHERINE trial and its impact on the treatment of HER2-positive breast cancer. And Ilana Yurkiewicz, MD, talks about whether it's better for physicians to be vague about prognosis. Show notes By Hitomi Hosoya, MD, PhD Resident in the department of internal medicine, University of Pennsylvania Health System The idea behind the KATHERINE trial was to determine whether trastuzumab emtansine (T-DM1) provides superior outcomes over trastuzumab in HER2-positive breast c...
2019-02-2825 min
Blood & CancerHow to read and review scientific papersDaniel G. Haller, MD, of the University of Pennsylvania joins David H. Henry, MD, to talk about the best ways to read and review the scientific literature. And Ilana Rachel Yurkiewicz, MD, talks about chaos and opportunity. Show notes By Hitomi Hosoya, MD, PhD, Resident in the department of internal medicine, University of Pennsylvania Health System - If you are a peer reviewer of a manuscript submitted to a journal, you should be unbiased, consistent, constructive, and focused on the research. COPE guideline is a good resource. - If you...
2019-02-2120 min
Blood & CancerESMO 2018 and moreDavid Henry, MD, welcomes Daniel G. Haller, MD, to rehash research from ESMO 2018 as well as the way the meeting itself was run. And Ilana Yurkiewicz, MD, stops by for this week’s Clinical Correlation. Dr. Yurkiewicz is a Hematology Fellow at Stanford and is also a columnist at MDedge Hematology/Oncology. More from Dr. Yurkiewicz here. Contact us: podcasts@mdedge.com MDedge on Twitter: @mdedgehemonc Dr. Ilana Yurkiewicz on Twitter: @ilanayurkiewicz SHOW NOTES By Emily Bryer, DO Resident in the department of internal medicine, University of P...
2019-02-1423 min
Blood & CancerBiosimilars: Gary Lyman In this episode, Gary H. Lyman, MD (https://bitly.is/2UJzUly) joins David Henry, MD, (http://bit.ly/2MFDfzm) to talk about biosimilars. Dr. Lyman talks about the definition of biosimilars, how they are made, which are approved, and which ones are on the market. He also talks about extrapolation and interchangeability as well as where some biosimilars stand in both ASCO and NCCN guidelines for patients who are going into supportive care. And Ilana Yurkiewicz, MD (https://stanford.io/2RXPixR), talks about what the word "cure" means to you compared to w...
2019-02-0729 min
Blood & CancerEp 01. Antiemetics: Richard GrallaIn the first episode of Blood & Cancer, David Henry, MD (http://bit.ly/2MFDfzm), welcomes Richard J. Gralla, MD (http://bit.ly/2ShsxEv), or the Albert Einstein College of Medicine in New York. The topic today centers around antiemetics and ways to use them. And later, Ilana Yurkiewicz, MD (https://stanford.io/2RXPixR), debuts her segment Clinical Correlations all about hematology care. Visit MDedge/hematology-oncology Show Notes By Emily Bryer, DO Highly emetic chemotherapy regimens include cisplatin, dacarbazine, anthracycline, and cyclophosphamide combinations Treatment should include an NK1 receptor antagonist, dexamethasone, and a 5H...
2019-01-3127 min